Houlihan Lokey Advises New Mountain Capital
Houlihan Lokey is pleased to share that New Mountain Capital has announced a strategic growth investment in Office Ally, which provides a comprehensive suite of cloud-based clearinghouse and software solutions to healthcare providers and payers. As part of the transaction, Francisco Partners, which originally invested in Office Ally in 2021, will reinvest alongside New Mountain Capital and management.
Office Ally is a healthcare technology company that offers cloud-based solutions tailored for healthcare providers, channel partners, and payers. Its comprehensive platform is trusted by more than 80,000 healthcare organizations of all sizes, from startups to Fortune 100 entities. The company’s all-payer clearinghouse connects healthcare organizations to a nationwide network, enabling the secure exchange of clinical and financial information to coordinate patient care and enable healthcare payments.
New Mountain Capital is a New York-based investment firm that emphasizes business building and growth—rather than excessive risk—as it pursues long-term capital appreciation. The firm currently manages private equity, strategic equity, credit, and net lease real estate funds with nearly $55 billion in assets under management. New Mountain Capital seeks out what it believes to be the highest-quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies.
Francisco Partners is a leading global investment firm that specializes in partnering with technology and technology-enabled businesses. Since its launch more than 25 years ago, Francisco Partners has invested in more than 450 technology companies, making it one of the most active and long-standing investors in the technology industry. With more than $50 billion in capital raised, the firm invests in opportunities where its deep sectoral knowledge and operational expertise can help companies realize their full potential.
This transaction demonstrates Houlihan Lokey’s continued success in healthcare technology, specifically in revenue cycle management (RCM), and marks the firm’s fifth RCM transaction in the past 12 months. Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the world. In 2024, the U.S. Healthcare Group closed 25 transactions and was ranked by LSEG as the No. 1 M&A advisor for all U.S. healthcare transactions.
RELATED: Global Healthcare Technology, Mergers & Acquisitions